|
KDM2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03709999477175E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09779999979409E-07 |
| Normal-vs-Stage2 |
1.053970E-02 |
| Normal-vs-Stage3 |
1.47740000011609E-07 |
| Normal-vs-Stage4 |
2.76810000032768E-07 |
| Stage1-vs-Stage2 |
1.068970E-01 |
| Stage1-vs-Stage3 |
2.519800E-01 |
| Stage1-vs-Stage4 |
1.119590E-01 |
| Stage2-vs-Stage3 |
3.258000E-02 |
| Stage2-vs-Stage4 |
1.431890E-02 |
| Stage3-vs-Stage4 |
5.313400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17499999952031E-07 |
| Normal-vs-AfricanAmerican |
6.457600E-03 |
| Normal-vs-Asian |
1.73140000003791E-06 |
| Caucasian-vs-AfricanAmerican |
5.425800E-01 |
| Caucasian-vs-Asian |
6.938200E-01 |
| AfricanAmerican-vs-Asian |
3.598200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67010000001944E-06 |
| Normal-vs-Female |
9.57049994809722E-09 |
| Male-vs-Female |
4.907800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65719999944969E-07 |
| Normal-vs-Age(41-60Yrs) |
1.60040000030115E-07 |
| Normal-vs-Age(61-80Yrs) |
4.21600000000133E-05 |
| Normal-vs-Age(81-100Yrs) |
7.699300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.890600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.532400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.273000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.853800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.889000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.662600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.217390E-01 |
| Classical-VS-Follicular |
1.686160E-01 |
| Classical-VS-Other |
8.172600E-01 |
| Classical-VS-Normal |
8.03269994964495E-09 |
| Tall-VS-Follicular |
2.472000E-02 |
| Tall-VS-Other |
6.141600E-01 |
| Tall-VS-Normal |
2.67229999995067E-06 |
| Follicular-VS-Other |
5.484200E-01 |
| Follicular-VS-Normal |
2.023600E-03 |
| Other-VS-Normal |
3.355900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.49880000002811E-06 |
| Normal-vs-N1 |
1.61350044436404E-10 |
| N0-vs-N1 |
1.232720E-04 |
|
|
